Manufacturing, Gene Therapies

FDA Approves First Cell-Based Gene Therapy for MCL

August 06, 2020

The therapy, indicated for a rare form of B-cell non-Hodgkin’s lymphoma, was developed by Kite, a Gilead company, which will manufacture the therapy at its facility in El Segundo, CA.

Novartis and Sangamo Announce Gene Therapy Collaboration for up to $795 Million

July 30, 2020

Sangamo will receive a $75 million upfront license fee payment and will be eligible to earn up to $720 million in other development and commercial milestone payments, including up to $420 million in development milestones and up to $300 million in commercial milestones.

A Novel Method for Host Cell Protein Analysis

July 13, 2020

This method is expected to help bring gene therapies to market faster, safer, and cheaper.

Can Using RNA Simplify Gene Therapy Development?

July 02, 2020

BioPharm International

RNA is easier to manipulate than DNA but challenging to deliver to the right cells.

Avantor Expands its New Jersey Innovation Center

June 30, 2020

The site can now support customized product and bioprocess development and custom cell and gene therapy reagent manufacturing.

uniQure, CSL Behring Collaborate on Hemophilia B Gene Therapy in Over $1.6-Billion Deal

June 29, 2020

The companies are entering into a license agreement to provide CSL Behring with exclusive global rights to etranacogene dezaparvovec, uniQure’s investigational gene therapy for patients with hemophilia B.

Emergent to Invest $75 Million to Expand Manufacturing Capabilities

June 22, 2020

The company will invest $75 million into its Canton, MA, facility to expand its viral vector, gene therapy, and contract development and manufacturing capabilities.

2019 Investments Centered around Cell and Gene Therapies

June 01, 2020

BioPharm International

Previous investments set a foundation for later efficiency improvements.

The Role of Incubators in Cell and Gene Therapy Development

June 01, 2020

BioPharm International

Working with incubators can provide cell and gene therapy developers with more opportunities.

Ori Biotech and CellGenix Collaborate on Closed-System, Cell and Gene Therapy Manufacturing

May 18, 2020

Ori Biotech is partnering with manufacturers and materials suppliers to develop an automated system for cell and gene therapy manufacturing.